Full Text View
Tabular View
Study Results
Related Studies
Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects
This study has been completed.
Study NCT00515203   Information provided by Amgen

First Received on August 9, 2007.   Last Updated on July 18, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial